EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Relapse of SLE associated with EBV infection in a patient after CAR-T cell therapy: a clinical case

Ping Zeng, Qi Ren, Xianfei Gao, Wei Xian, Pui Y Lee, Feng Li, Caihong Xu, Mingqi Zhao, Wenhao Zhou

Frontiers in Immunology · 2026

DOI: 10.3389/fimmu.2026.1956166 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Immunology, 2026. Verfasst von Ping Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Zunyi Medical University, Zunyi, Guizhou, China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Lupus Erythematosus, Systemic, Immunotherapy, Adoptive, Herpesvirus 4, Human. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present the case of a 13-year-old boy with refractory systemic lupus erythematosus (SLE) who achieved drug-free remission after anti-CD19 CAR-T cell therapy, but subsequently experienced Epstein–Barr virus (EBV) reactivation on day 142 after CAR T-cell infusion and peak EBV load was 24,400 IU/mL with a severe drop in platelets to 8×10 9 /L, which leading to relapse of SLE and manifestations of chronic active EBV disease (CAEBVD). The whole exogenous gene testing found X chromosome Xp22.33q28 region (chrX: 200855-155239820) a duplicate of about 155.04Mbp,which is associated with the development of Klinefelter syndrome (KS).The temporal association between EBV resurgence and SLE flare suggests that CAR-T-induced immunosuppression with some genetic background may permit EBV reactivation, which can be associated with the return of autoimmunity. This case highlights the need for vigilant monitoring for opportunistic infections and genetic background, particularly EBV, after CAR-T therapy for autoimmune diseases, as they may contribute to disease relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsLupus Erythematosus, SystemicImmunotherapy, AdoptiveHerpesvirus 4, HumanHumansMaleRecurrenceAdolescentVirus Activation

Stichwörter der Autor:innen

CAR- T cell therapyEpstein–Barr viruschronic active EBV diseasepediatric lupusreactivationsystemic lupus erythematosus

Autor:innen und Institutionen

  • Zunyi Medical University, Zunyi, Guizhou, China.
  • Department of Pediatric, Allergy Immune & Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, China.
  • Division of Immunology, Harvard Medical School, Boston, MA, United States.

Zitieren

APA

Zeng, P., Ren, Q., Gao, X., Xian, W., Lee, P. Y., Li, F., Xu, C., Zhao, M., & Zhou, W. (2026). Case Report: Relapse of SLE associated with EBV infection in a patient after CAR-T cell therapy: a clinical case. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1956166

Vancouver

Zeng P, Ren Q, Gao X, Xian W, Lee PY, Li F, et al. Case Report: Relapse of SLE associated with EBV infection in a patient after CAR-T cell therapy: a clinical case. Frontiers in Immunology. 2026. doi:10.3389/fimmu.2026.1956166

BibTeX
@article{Zeng2026,
  author = {Zeng, Ping and Ren, Qi and Gao, Xianfei and Xian, Wei and Lee, Pui Y and Li, Feng and Xu, Caihong and Zhao, Mingqi and Zhou, Wenhao},
  title = {Case Report: Relapse of SLE associated with EBV infection in a patient after CAR-T cell therapy: a clinical case},
  journal = {Frontiers in Immunology},
  year = {2026},
  doi = {10.3389/fimmu.2026.1956166}
}
Kostenlos starten →